The global market for Monoclonal Antibody Service was valued at US$ 7736 million in the year 2024 and is projected to reach a revised size of US$ 9423 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Monoclonal Antibody Service Market

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.

North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Service.

The Monoclonal Antibody Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibody Service Market Report

Report Metric	Details
Report Name	Monoclonal Antibody Service Market
Accounted market size in year	US$ 7736 million
Forecasted market size in 2031	US$ 9423 million
CAGR	2.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Reagents Drugs Other
Segment by Application	Diagnostic Laboratories Research & Academic Laboratories Pharmaceutical & Biotechnology Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Merck, Abbott Laboratories, GSK, BMS, Alexion, UCB, Seattle Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibody Service Market growing?

Ans: The Monoclonal Antibody Service Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Monoclonal Antibody Service Market size in 2031?

Ans: The Monoclonal Antibody Service Market size in 2031 will be US$ 9423 million.

What is the Monoclonal Antibody Service Market share by region?

Ans: North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year.

What is the Monoclonal Antibody Service Market share by type?

Ans: All the other regions combined occupy only 8% of the global Antibody Service market.

Who are the main players in the Monoclonal Antibody Service Market report?

Ans: The main players in the Monoclonal Antibody Service Market are Pfizer, Roche, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Merck, Abbott Laboratories, GSK, BMS, Alexion, UCB, Seattle Genetics

What are the Application segmentation covered in the Monoclonal Antibody Service Market report?

Ans: The Applications covered in the Monoclonal Antibody Service Market report are Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies

What are the Type segmentation covered in the Monoclonal Antibody Service Market report?

Ans: The Types covered in the Monoclonal Antibody Service Market report are Reagents, Drugs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoclonal Antibody Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Reagents

1.2.3 Drugs

1.2.4 Other

1.3 Market by Application

1.3.1 Global Monoclonal Antibody Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostic Laboratories

1.3.3 Research & Academic Laboratories

1.3.4 Pharmaceutical & Biotechnology Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoclonal Antibody Service Market Perspective (2020-2031)

2.2 Global Monoclonal Antibody Service Growth Trends by Region

2.2.1 Global Monoclonal Antibody Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Monoclonal Antibody Service Historic Market Size by Region (2020-2025)

2.2.3 Monoclonal Antibody Service Forecasted Market Size by Region (2026-2031)

2.3 Monoclonal Antibody Service Market Dynamics

2.3.1 Monoclonal Antibody Service Industry Trends

2.3.2 Monoclonal Antibody Service Market Drivers

2.3.3 Monoclonal Antibody Service Market Challenges

2.3.4 Monoclonal Antibody Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Monoclonal Antibody Service Players by Revenue

3.1.1 Global Top Monoclonal Antibody Service Players by Revenue (2020-2025)

3.1.2 Global Monoclonal Antibody Service Revenue Market Share by Players (2020-2025)

3.2 Global Monoclonal Antibody Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Monoclonal Antibody Service Revenue

3.4 Global Monoclonal Antibody Service Market Concentration Ratio

3.4.1 Global Monoclonal Antibody Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Service Revenue in 2024

3.5 Global Key Players of Monoclonal Antibody Service Head office and Area Served

3.6 Global Key Players of Monoclonal Antibody Service, Product and Application

3.7 Global Key Players of Monoclonal Antibody Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Service Breakdown Data by Type

4.1 Global Monoclonal Antibody Service Historic Market Size by Type (2020-2025)

4.2 Global Monoclonal Antibody Service Forecasted Market Size by Type (2026-2031)

5 Monoclonal Antibody Service Breakdown Data by Application

5.1 Global Monoclonal Antibody Service Historic Market Size by Application (2020-2025)

5.2 Global Monoclonal Antibody Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Monoclonal Antibody Service Market Size (2020-2031)

6.2 North America Monoclonal Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Monoclonal Antibody Service Market Size by Country (2020-2025)

6.4 North America Monoclonal Antibody Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Monoclonal Antibody Service Market Size (2020-2031)

7.2 Europe Monoclonal Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Monoclonal Antibody Service Market Size by Country (2020-2025)

7.4 Europe Monoclonal Antibody Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Monoclonal Antibody Service Market Size (2020-2031)

8.2 Asia-Pacific Monoclonal Antibody Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Monoclonal Antibody Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Monoclonal Antibody Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Monoclonal Antibody Service Market Size (2020-2031)

9.2 Latin America Monoclonal Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Monoclonal Antibody Service Market Size by Country (2020-2025)

9.4 Latin America Monoclonal Antibody Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Monoclonal Antibody Service Market Size (2020-2031)

10.2 Middle East & Africa Monoclonal Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Monoclonal Antibody Service Introduction

11.1.4 Pfizer Revenue in Monoclonal Antibody Service Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Monoclonal Antibody Service Introduction

11.2.4 Roche Revenue in Monoclonal Antibody Service Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Monoclonal Antibody Service Introduction

11.3.4 Eli Lilly Revenue in Monoclonal Antibody Service Business (2020-2025)

11.3.5 Eli Lilly Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Monoclonal Antibody Service Introduction

11.4.4 Bayer Revenue in Monoclonal Antibody Service Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Amgen

11.5.1 Amgen Company Details

11.5.2 Amgen Business Overview

11.5.3 Amgen Monoclonal Antibody Service Introduction

11.5.4 Amgen Revenue in Monoclonal Antibody Service Business (2020-2025)

11.5.5 Amgen Recent Development

11.6 Sanofi-Aventis

11.6.1 Sanofi-Aventis Company Details

11.6.2 Sanofi-Aventis Business Overview

11.6.3 Sanofi-Aventis Monoclonal Antibody Service Introduction

11.6.4 Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2020-2025)

11.6.5 Sanofi-Aventis Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Monoclonal Antibody Service Introduction

11.7.4 Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Novo Nordisk

11.8.1 Novo Nordisk Company Details

11.8.2 Novo Nordisk Business Overview

11.8.3 Novo Nordisk Monoclonal Antibody Service Introduction

11.8.4 Novo Nordisk Revenue in Monoclonal Antibody Service Business (2020-2025)

11.8.5 Novo Nordisk Recent Development

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Monoclonal Antibody Service Introduction

11.9.4 Merck Revenue in Monoclonal Antibody Service Business (2020-2025)

11.9.5 Merck Recent Development

11.10 Abbott Laboratories

11.10.1 Abbott Laboratories Company Details

11.10.2 Abbott Laboratories Business Overview

11.10.3 Abbott Laboratories Monoclonal Antibody Service Introduction

11.10.4 Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2020-2025)

11.10.5 Abbott Laboratories Recent Development

11.11 GSK

11.11.1 GSK Company Details

11.11.2 GSK Business Overview

11.11.3 GSK Monoclonal Antibody Service Introduction

11.11.4 GSK Revenue in Monoclonal Antibody Service Business (2020-2025)

11.11.5 GSK Recent Development

11.12 BMS

11.12.1 BMS Company Details

11.12.2 BMS Business Overview

11.12.3 BMS Monoclonal Antibody Service Introduction

11.12.4 BMS Revenue in Monoclonal Antibody Service Business (2020-2025)

11.12.5 BMS Recent Development

11.13 Alexion

11.13.1 Alexion Company Details

11.13.2 Alexion Business Overview

11.13.3 Alexion Monoclonal Antibody Service Introduction

11.13.4 Alexion Revenue in Monoclonal Antibody Service Business (2020-2025)

11.13.5 Alexion Recent Development

11.14 UCB

11.14.1 UCB Company Details

11.14.2 UCB Business Overview

11.14.3 UCB Monoclonal Antibody Service Introduction

11.14.4 UCB Revenue in Monoclonal Antibody Service Business (2020-2025)

11.14.5 UCB Recent Development

11.15 Seattle Genetics

11.15.1 Seattle Genetics Company Details

11.15.2 Seattle Genetics Business Overview

11.15.3 Seattle Genetics Monoclonal Antibody Service Introduction

11.15.4 Seattle Genetics Revenue in Monoclonal Antibody Service Business (2020-2025)

11.15.5 Seattle Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Monoclonal Antibody Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Reagents

Table 3. Key Players of Drugs

Table 4. Key Players of Other

Table 5. Global Monoclonal Antibody Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Monoclonal Antibody Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Monoclonal Antibody Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Monoclonal Antibody Service Market Share by Region (2020-2025)

Table 9. Global Monoclonal Antibody Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Monoclonal Antibody Service Market Share by Region (2026-2031)

Table 11. Monoclonal Antibody Service Market Trends

Table 12. Monoclonal Antibody Service Market Drivers

Table 13. Monoclonal Antibody Service Market Challenges

Table 14. Monoclonal Antibody Service Market Restraints

Table 15. Global Monoclonal Antibody Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Monoclonal Antibody Service Market Share by Players (2020-2025)

Table 17. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Service as of 2024)

Table 18. Ranking of Global Top Monoclonal Antibody Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Monoclonal Antibody Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Monoclonal Antibody Service, Headquarters and Area Served

Table 21. Global Key Players of Monoclonal Antibody Service, Product and Application

Table 22. Global Key Players of Monoclonal Antibody Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Monoclonal Antibody Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Monoclonal Antibody Service Revenue Market Share by Type (2020-2025)

Table 26. Global Monoclonal Antibody Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Monoclonal Antibody Service Revenue Market Share by Type (2026-2031)

Table 28. Global Monoclonal Antibody Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Monoclonal Antibody Service Revenue Market Share by Application (2020-2025)

Table 30. Global Monoclonal Antibody Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Monoclonal Antibody Service Revenue Market Share by Application (2026-2031)

Table 32. North America Monoclonal Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Monoclonal Antibody Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Monoclonal Antibody Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Monoclonal Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Monoclonal Antibody Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Monoclonal Antibody Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Monoclonal Antibody Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Monoclonal Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Monoclonal Antibody Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Monoclonal Antibody Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Monoclonal Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Monoclonal Antibody Service Product

Table 50. Pfizer Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Monoclonal Antibody Service Product

Table 55. Roche Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Eli Lilly Company Details

Table 58. Eli Lilly Business Overview

Table 59. Eli Lilly Monoclonal Antibody Service Product

Table 60. Eli Lilly Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 61. Eli Lilly Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Monoclonal Antibody Service Product

Table 65. Bayer Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. Amgen Company Details

Table 68. Amgen Business Overview

Table 69. Amgen Monoclonal Antibody Service Product

Table 70. Amgen Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 71. Amgen Recent Development

Table 72. Sanofi-Aventis Company Details

Table 73. Sanofi-Aventis Business Overview

Table 74. Sanofi-Aventis Monoclonal Antibody Service Product

Table 75. Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 76. Sanofi-Aventis Recent Development

Table 77. Johnson & Johnson Company Details

Table 78. Johnson & Johnson Business Overview

Table 79. Johnson & Johnson Monoclonal Antibody Service Product

Table 80. Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 81. Johnson & Johnson Recent Development

Table 82. Novo Nordisk Company Details

Table 83. Novo Nordisk Business Overview

Table 84. Novo Nordisk Monoclonal Antibody Service Product

Table 85. Novo Nordisk Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 86. Novo Nordisk Recent Development

Table 87. Merck Company Details

Table 88. Merck Business Overview

Table 89. Merck Monoclonal Antibody Service Product

Table 90. Merck Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 91. Merck Recent Development

Table 92. Abbott Laboratories Company Details

Table 93. Abbott Laboratories Business Overview

Table 94. Abbott Laboratories Monoclonal Antibody Service Product

Table 95. Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 96. Abbott Laboratories Recent Development

Table 97. GSK Company Details

Table 98. GSK Business Overview

Table 99. GSK Monoclonal Antibody Service Product

Table 100. GSK Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 101. GSK Recent Development

Table 102. BMS Company Details

Table 103. BMS Business Overview

Table 104. BMS Monoclonal Antibody Service Product

Table 105. BMS Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 106. BMS Recent Development

Table 107. Alexion Company Details

Table 108. Alexion Business Overview

Table 109. Alexion Monoclonal Antibody Service Product

Table 110. Alexion Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 111. Alexion Recent Development

Table 112. UCB Company Details

Table 113. UCB Business Overview

Table 114. UCB Monoclonal Antibody Service Product

Table 115. UCB Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 116. UCB Recent Development

Table 117. Seattle Genetics Company Details

Table 118. Seattle Genetics Business Overview

Table 119. Seattle Genetics Monoclonal Antibody Service Product

Table 120. Seattle Genetics Revenue in Monoclonal Antibody Service Business (2020-2025) & (US$ Million)

Table 121. Seattle Genetics Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Monoclonal Antibody Service Picture

Figure 2. Global Monoclonal Antibody Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoclonal Antibody Service Market Share by Type: 2024 VS 2031

Figure 4. Reagents Features

Figure 5. Drugs Features

Figure 6. Other Features

Figure 7. Global Monoclonal Antibody Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Monoclonal Antibody Service Market Share by Application: 2024 VS 2031

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Research & Academic Laboratories Case Studies

Figure 11. Pharmaceutical & Biotechnology Companies Case Studies

Figure 12. Monoclonal Antibody Service Report Years Considered

Figure 13. Global Monoclonal Antibody Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Monoclonal Antibody Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Monoclonal Antibody Service Market Share by Region: 2024 VS 2031

Figure 16. Global Monoclonal Antibody Service Market Share by Players in 2024

Figure 17. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Service Revenue in 2024

Figure 19. North America Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Monoclonal Antibody Service Market Share by Country (2020-2031)

Figure 21. United States Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Monoclonal Antibody Service Market Share by Country (2020-2031)

Figure 25. Germany Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Monoclonal Antibody Service Market Share by Region (2020-2031)

Figure 33. China Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Monoclonal Antibody Service Market Share by Country (2020-2031)

Figure 41. Mexico Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Monoclonal Antibody Service Market Share by Country (2020-2031)

Figure 45. Turkey Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Monoclonal Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 50. Eli Lilly Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 51. Bayer Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 52. Amgen Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 53. Sanofi-Aventis Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 55. Novo Nordisk Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 56. Merck Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 57. Abbott Laboratories Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 58. GSK Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 59. BMS Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 60. Alexion Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 61. UCB Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 62. Seattle Genetics Revenue Growth Rate in Monoclonal Antibody Service Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions